Schedule-dependent pharmacodynamic effects of gemcitabine and cisplatin in mice bearing Lewis lung murine non-small cell lung tumours

By van Moorsel C.J.A.   Pinedo H.M.   Smid K.   Comijn E.M.   Voorn D.A.   Veerman G.   Lakerveld B.   Van der Vijgh W.J.F.   Giaccone G.   Postmus P.E.   Peters G.J.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2420-2429

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of cisplatin with and without amifostine in tumour-bearing nude mice

By Korst A.E.C.   Boven E.   van der Sterre M.L.T.   Fichtinger-Schepman A.M.J.   van der Vijgh W.J.F.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 412-416

Elsevier

Access to resources Recommend Favorite

Avastin® in combination with gemcitabine and cisplatin significantly inhibits tumor angiogenesis and increases the survival rate of human A549 tumor-bearing mice

By        

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2180-2184

Spandidos Publications

Access to resources Recommend Favorite

Pharmacology of the paclitaxel–cisplatin, gemcitabine–cisplatin, and paclitaxel–gemcitabine combinations in patients with advanced non-small cell lung cancer

By Kroep J.   Smit E.   Giaccone G.   Born K.   Beijnen J.   Groeningen C.   Vijgh W.   Postmus P.   Pinedo H.   Peters G.  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 509-516

Springer Publishing Company

Access to resources Recommend Favorite

Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells

By Saitoh Minori   Taguchi Katsunari   Momose Kazuhiro   Suga Kazutaka   Yamazaki Noriyuki   Ono Chizuko   Suzuki Tatsuo   Takeuchi Osamu   Yasuda Shuhei   Miyata Keiji  

Cancer Chemotherapy and Pharmacology, Vol. 49, Iss. 2, 2002-02 ,pp. : 161-166

Springer Publishing Company

Access to resources Recommend Favorite